Abstract:Background The long-term safety and efficacy of drug-eluting stents (DES) versus bare metal stents (BMS) are unclear and controversial issues in patients with acute ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). The purpose of this study was to compare the long-term outcome of STEMI patients undergoing primary PCI with DES versus BMS implantation.Methods A total of 191 patients with acute STEMI undergoing PCI from Jan. 2005 to Dec. 2007 were enrolled. Patients received DES (n=83) or BMS (n=108) implantation in the infarction related artery according to physician's discretion. The primary outcome was the occurrence of major adverse cardiac events (MACE), which was defined as a composite of death, myocardial infarction (MI), target vessel revascularization (TVR) and stent thrombosis. The difference of MACE was observed between DES and BMS groups.Results The clinical follow-up duration was 3 years ((41.7 +/- 16.1) months). MACE occurred in 20 patients during three years follow-up. Logistic regression analysis showed that the left ventricular ejection fraction (LVEF) was an independent predictor for MACE in the follow-up period (P=0.0301). There was no significant difference in all-cause mortality (3.61% vs. 7.41%, P=0.2647), the incidence of myocardial infarction (0 vs. 0.93%, P=0.379) and stent thrombosis (1.20% vs. 1.85%, P=0.727) between the DES group and BMS group. The incidence of MACE was significantly lower in the DES group compared to the BMS group (4.82% vs. 14.81%, P=0.0253). The rate of TVR was also lower in the DES group (0 vs. 5.56%, P=0.029). In the DES group, there was no significant difference in the incidence of MACE between sirolimus eluting stents (SES, n=73) and paclitaxel-eluting stents (PES, n=10) subgroups (2.74% vs. 20.00%, P>0.05).Conclusions This finding suggested that drug-eluting stents significantly reduced the need for revascularization in patients with acute STEMI, without increasing the incidence of death or myocardial infarction. Use of DES significantly decreased the incidence of MACE compared with BMS during the 3-year follow-up. Chin Med J 2012;125(16):2803-2806

The Application of CypherTM Drug-Eluting Stent in Patient with Unstable Angina Treated by Percutaneous Coronary Intervention

The application of cypherTM drug-eluting stent in patient with ST-segment elevation myocardial infarction receiving emergency percutaneous coronary intervention

[The Safety and Efficacy of Cypher Drug-Eluting Stent: Results from a Six Months Follow-Up Study in Patients with ST-segment Elevation Myocardial Infarction].

Safety and Efficacy of the Cypher Select Sirolimus-Eluting Stent in the "real World" - Clinical and Angiographic Results from the China Cypher Select Registry

The Application of CypherTM Drug-Eluting Stent in Elderly Patients with Acute Myocardial Infarction Treated with Emergency Percutaneous Coronary Intervention

Clinical Outcomes and Risk Factors of Coronary Artery Aneurysms after Successful Percutaneous Coronary Intervention and Drug-Eluting Stent Implantation for Chronic Total Occlusions

Long-term Outcome Comparison of Ostial/shaft Lesions in Unprotected Left Main Coronary Artery Treated by PCI or CABG

Long-Term Effects of Drug-Eluting Stents Versus Bare Metal Stents on Patients with Acute St-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Outcomes of 3-Year Clinical Follow-Up

Effectiveness of drug eluting stents in patients with small coronary artery lesions

Mid-term result of implantation of drug eluted stent for diabetic patients with multivessel coronary artery lesions

Two-year results and subgroup analyses of the PEPCAD China in-stent restenosis trial: A prospective, multicenter, randomized trial for the treatment of drug-eluting stent in-stent restenosis.

The clinical safety and short-term therapeutic efficacy of EXCEL drug-eluting stent

The Status and Prospect of Drug-Eluting Stents(DES) in Percutaneous Coronary Intervention(PCI)

The Clinical Study of CYPHER ~(TM) Stent in Long Lesion of Left Anterior Descending Artery

Safety and short-term outcome of multivessel percutanous coronary revascularization after acute myocardial infarction

Complex Coronary Lesions and Rotational Atherectomy: One Hospital's Experience.

Drug-Eluting Stent Implantation in ST-Elevation Acute Myocardial Infarction

A study of treatment with different drug eluting stents in coronary heart disease

AS-023: Efficacy and Safety of a Novel Non-Symmetrical, Biodegradable Polymer-Coated Sirolimus-Eluting Stent in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Effect of Drug Eluting stent Implantation in the Treatment of Coronary Artery In-stent Restenosis in a Longterm Clinical Follow-up

Percutaneous Treatment with Drug-Eluting Stent Vs Bypass Surgery in Patients Suffering from Chronic Stable Angina with Multivessel Disease Involving Significant Proximal Stenosis in Left Anterior Descending Artery